This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, M.-L. Articles by Moore, M. J. Search for Related Content PubMed PubMed Citation Articles by Li, M.-L. Articles by Moore, M. J.

Pharmacological Determinants of 9-Aminocamptothecin Cytotoxicity

Faculty of Pharmacy [M-L. L., M. J. M.], Pharmacology [L. H., M. J. M.] University of Toronto, Toronto, Ontario M5G 2S2, and Department of Medicine, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario M5G 2M9 [M. J. M., P. S. F.], Canada

The camptothecins are a group of anticancer agents with a unique mechanism of action: poisoning of eukaryotic DNA topoisomerase I. 9-aminocamptothecin (9-AC), a potent water-insoluble derivative of camptothecin, is currently undergoing clinical testing. The kinetics of the active derivative 9-AC lactone in cell culture media was defined, and then 9-AC cytotoxicity against human breast (MCF-7), bladder (MGH-U1), and colon (HT-29) cancer cell lines was studied. The relationship between cytotoxic effects, drug concentration, and exposure time was then explored. For all of the three cell lines, 9-AC cytotoxicity increased with both higher drug concentrations and longer exposure times. However, when the duration of exposure was less than 24 h, cytotoxicity was limited and less than 1 log of cell killing occurred, even with very high drug concentrations. Minimal cell killing was also observed unless 9-AC concentrations exceeded a threshold of 2.7 nM. No fixed relationship between the survival fraction and the area under the drug concentration-time curve could be modeled that would fit all of the three cell lines. However, data for the three cell lines from the multiple exposure time experiments were fitted very well to the pharmacodynamic model Cⁿt = k (r²,0.90–0.99), where C is the drug concentration, n is the drug concentration coefficient, and t is the exposure time. For the three cell lines, to kill 1 log of cells, 0.30 < n < 0.85, which indicated that duration of exposure was more important than concentration. Our data support the use of 9-AC by infusion for 24 h or longer in clinical studies providing target plasma concentrations can be achieved.

This article has been cited by other articles:

				H. Hochster, E. R. Plimack, C. D. Runowicz, J. Speyer, R. C. Wallach, J. Sorich, J. Mandeli, S. Wadler, J. Wright, and F. M. Muggia Biweekly 72-Hour 9-Aminocamptothecin Infusion As Second-Line Therapy for Ovarian Carcinoma: Phase II Study of the New York Gynecologic Oncology Group and the Eastern Cooperative Oncology Group J. Clin. Oncol., January 1, 2004; 22(1): 120 - 126. [Abstract] [Full Text] [PDF]

				S. Sakuma, Z.-R. Lu, B. Pecharova, P. Kopeckova, and J. Kopecek N-(2-Hydroxypropyl)methacrylamide Copolymer-9-Aminocamptothecin Conjugate: Colon-Specific Drug Delivery in Rats Journal of Bioactive and Compatible Polymers, September 1, 2002; 17(5): 305 - 319. [Abstract] [PDF]